Clinical Outcomes of Second- versus First-Generation Carotid Stents: A Systematic Review and Meta-Analysis
Authors:
- Adam MazurekAMAdam Mazurek
- Krzysztof MalinowskiKMKrzysztof Malinowski
- Kenneth RosenfieldKRKenneth Rosenfield
- Laura CapocciaLCLaura Capoccia
- Francesco SpezialeFSFrancesco Speziale
- Gianmarco de DonatoGianmarco de Donato
- Carlo SetacciCarlo Setacci
- Christian WissgottCWChristian Wissgott
- Pasqualino SirignanoPasqualino Sirignano
- Lukasz TekieliLTLukasz Tekieli
- Andrey KarpenkoAKAndrey Karpenko
- Waclaw KuczmikWKWaclaw Kuczmik
Open Access
- 17 August 2022
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (16) , 4819
Abstract
Background: Single-cohort studies suggest that second-generation stents (SGS; “mesh stents”) may improve carotid artery stenting (CAS) outcomes by limiting peri- and postprocedural cerebral embolism. SGS differ in the stent frame construction, mesh material, and design, as well as in mesh-to-frame position (inside/outside). Objectives: To compare clinical outcomes of SGS in relation to first-generation stents (FGSs; single-layer) in CAS. Methods: We performed a systematic review and meta-analysis of clinical studies with FGSs and SGS (PRISMA methodology, 3302 records). Endpoints were 30-day death, stroke, myocardial infarction (DSM), and 12-month ipsilateral stroke (IS) and restenosis (ISR). A random-effect model was applied. Results: Data of 68,422 patients from 112 eligible studies (68.2% men, 44.9% symptomatic) were meta-analyzed. Thirty-day DSM was 1.30% vs. 4.11% (p < 0.01, data for SGS vs. FGS). Among SGS, both Casper/Roadsaver and CGuard reduced 30-day DSM (by 2.78 and 3.03 absolute percent, p = 0.02 and p < 0.001), whereas the Gore stent was neutral. SGSs significantly improved outcomes compared with closed-cell FGS (30-day stroke 0.6% vs. 2.32%, p = 0.014; DSM 1.3% vs. 3.15%, p < 0.01). At 12 months, in relation to FGS, Casper/Roadsaver reduced IS (−3.25%, p < 0.05) but increased ISR (+3.19%, p = 0.04), CGuard showed a reduction in both IS and ISR (−3.13%, −3.63%; p = 0.01, p < 0.01), whereas the Gore stent was neutral. Conclusions: Pooled SGS use was associated with improved short- and long-term clinical results of CAS. Individual SGS types, however, differed significantly in their outcomes, indicating a lack of a “mesh stent” class effect. Findings from this meta-analysis may provide clinically relevant information in anticipation of large-scale randomized trials.Keywords
Funding Information
- Jagiellonian University Research (K/ZDS/007819, N41/DBS/000822)
- John Paul II Hospital in Krakow Research Fund (K/ZDS/007819, N41/DBS/000822)
This publication has 239 references indexed in Scilit:
- United Kingdom Carotid Artery Stent Registry: Short- and Long-Term OutcomesCardioVascular and Interventional Radiology, 2013
- Comparison of mid-term outcomes of carotid artery stenting for moderate versus critical stenosisArchives of Medical Science, 2012
- Society for Vascular Surgery Vascular Registry evaluation of stent cell design on carotid artery stenting outcomesJournal of Vascular Surgery, 2011
- Mechanisms to explain the poor results of carotid artery stenting (CAS) in symptomatic patients to date and options to improve CAS outcomesJournal of Vascular Surgery, 2010
- CAPTURE 2 risk-adjusted stroke outcome benchmarks for carotid artery stenting with distal embolic protectionJournal of Vascular Surgery, 2010
- Protected Carotid Stenting in High‐Risk Patients: Results of the SpideRX Arm of the Carotid Revascularization with ev3 Arterial Technology Evolution TrialJournal of Interventional Cardiology, 2010
- Stenting versus Endarterectomy for Treatment of Carotid-Artery StenosisNew England Journal of Medicine, 2010
- Primary carotid artery stenting versus carotid artery stenting for postcarotid endarterectomy stenosisJournal of Vascular Surgery, 2009
- Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trialThe Lancet Neurology, 2009
- Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trialThe Lancet Neurology, 2009